These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark One) | |||||
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
||||||||||
(State or other jurisdiction of incorporation or organization) | (IRS employer identification number) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
|
|
|
||||||||||||
|
|
|
|
☑ | Accelerated Filer | ☐ | ||||||||
Non-accelerated Filer | ☐ | Smaller Reporting Company |
|
||||||||
(Do not check if a smaller reporting company) | Emerging growth company |
|
PART I – FINANCIAL INFORMATION | Page No. | |||||||
PART II – OTHER INFORMATION | ||||||||
Apr. 2, 2022 | Jul. 3, 2021 | ||||||||||||||||
(unaudited) | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets | |||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||||||||
Accounts receivable, less allowances of $126,580 and $117,695 |
|
|
|||||||||||||||
Inventories |
|
|
|||||||||||||||
Prepaid expenses and other current assets |
|
|
|||||||||||||||
Income tax receivable |
|
|
|||||||||||||||
Total current assets |
|
|
|||||||||||||||
Plant and equipment at cost, less accumulated depreciation |
|
|
|||||||||||||||
Other long-term assets | |||||||||||||||||
Goodwill |
|
|
|||||||||||||||
Intangibles, less amortization |
|
|
|||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||
Operating lease right-of-use assets, net |
|
|
|||||||||||||||
Other assets |
|
|
|||||||||||||||
Total other long-term assets |
|
|
|||||||||||||||
Total assets | $ |
|
$ |
|
|||||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||||||
Current liabilities | |||||||||||||||||
Notes payable | $ |
|
$ |
|
|||||||||||||
Accounts payable |
|
|
|||||||||||||||
Accrued expenses |
|
|
|||||||||||||||
Accrued income taxes |
|
|
|||||||||||||||
Current operating lease liabilities |
|
|
|||||||||||||||
Current maturities of long-term debt |
|
|
|||||||||||||||
Total current liabilities |
|
|
|||||||||||||||
Long-term liabilities | |||||||||||||||||
Long-term debt |
|
|
|||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||
Long-term operating lease liabilities |
|
|
|||||||||||||||
Other long-term liabilities |
|
|
|||||||||||||||
Total long-term liabilities |
|
|
|||||||||||||||
Noncontrolling interest |
|
|
|||||||||||||||
Shareholders’ equity | |||||||||||||||||
Preferred stock, par value $1 per share Authorized 1,500,000 shares, issued none |
|
|
|||||||||||||||
Common stock, par value $1 per share Authorized 2,000,000,000 shares, issued 765,174,900 shares |
|
|
|||||||||||||||
Paid-in capital |
|
|
|||||||||||||||
Retained earnings |
|
|
|||||||||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||||||||
Treasury stock at cost, 256,507,982 and 253,342,595 shares |
(
|
(
|
|||||||||||||||
Total shareholders’ equity |
|
|
|||||||||||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||||||||||||
Sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Cost of sales |
|
|
|
|
|||||||||||||||||||
Gross profit |
|
|
|
|
|||||||||||||||||||
Operating expenses |
|
|
|
|
|||||||||||||||||||
Operating income |
|
|
|
|
|||||||||||||||||||
Interest expense |
|
|
|
|
|||||||||||||||||||
Other income, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Earnings before income taxes |
|
|
|
|
|||||||||||||||||||
Income taxes |
|
|
|
|
|||||||||||||||||||
Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net earnings: | |||||||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share |
|
|
|
|
|||||||||||||||||||
Average shares outstanding |
|
|
|
|
|||||||||||||||||||
Diluted shares outstanding |
|
|
|
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||||||||||||
Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other comprehensive (loss) income: | |||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
|
(
|
|
|||||||||||||||||||
Items presented net of tax: | |||||||||||||||||||||||
Amortization of cash flow hedges |
|
|
|
|
|||||||||||||||||||
Change in net investment hedges |
|
|
|
(
|
|||||||||||||||||||
Change in cash flow hedges |
|
|
|
|
|||||||||||||||||||
Amortization of prior service cost |
|
|
|
|
|||||||||||||||||||
Amortization of actuarial gain |
|
|
|
|
|||||||||||||||||||
Change in marketable securities |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive (loss) income |
(
|
|
(
|
|
|||||||||||||||||||
Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of January 1, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Amortization of cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in net investment hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Reclassification of pension and other postretirement benefit plans amounts to net earnings, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in marketable securities, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($0.47 per common share) |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of April 2, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of December 26, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Amortization of cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in net investment hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Reclassification of pension and other postretirement benefit plans amounts to net earnings, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in marketable securities, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($0.45 per common share) |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of March 27, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of July 3, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Amortization of cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in net investment hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Reclassification of pension and other postretirement benefit plans amounts to net earnings, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in marketable securities, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($1.41 per common share) |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
Increase in ownership interest in subsidiaries |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of April 2, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of June 27, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Amortization of cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in cash flow hedges, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in net investment hedges, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Reclassification of pension and other postretirement benefit plans amounts to net earnings, net of tax |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Change in marketable securities, net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Adoption of ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), net of tax |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($1.35 per common share) |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of March 27, 2021 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
39-Week Period Ended | |||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net earnings | $ |
|
$ |
|
|||||||
Adjustments to reconcile net earnings to cash provided by operating activities: | |||||||||||
Share-based compensation expense |
|
|
|||||||||
Depreciation and amortization |
|
|
|||||||||
Operating lease asset amortization |
|
|
|||||||||
Amortization of debt issuance and other debt-related costs |
|
|
|||||||||
Deferred income taxes |
(
|
(
|
|||||||||
Provision for losses on receivables |
|
(
|
|||||||||
Loss on extinguishment of debt |
|
|
|||||||||
Loss on sale of business |
|
|
|||||||||
Other non-cash items |
(
|
(
|
|||||||||
Additional changes in certain assets and liabilities, net of effect of businesses acquired: | |||||||||||
Increase in receivables |
(
|
(
|
|||||||||
Increase in inventories |
(
|
(
|
|||||||||
Increase in prepaid expenses and other current assets |
(
|
(
|
|||||||||
Increase in accounts payable |
|
|
|||||||||
Increase in accrued expenses |
|
|
|||||||||
Decrease in operating lease liabilities |
(
|
(
|
|||||||||
(Decrease) increase in accrued income taxes |
(
|
|
|||||||||
(Increase) decrease in other assets |
(
|
|
|||||||||
(Decrease) increase in other long-term liabilities |
(
|
|
|||||||||
Net cash provided by operating activities |
|
|
|||||||||
Cash flows from investing activities: | |||||||||||
Additions to plant and equipment |
(
|
(
|
|||||||||
Proceeds from sales of plant and equipment |
|
|
|||||||||
Acquisition of businesses, net of cash acquired |
(
|
|
|||||||||
Purchase of marketable securities |
(
|
(
|
|||||||||
Proceeds from sales of marketable securities |
|
|
|||||||||
Other investing activities |
|
|
|||||||||
Net cash used for investing activities |
(
|
(
|
|||||||||
Cash flows from financing activities: | |||||||||||
Bank and commercial paper borrowings, net |
|
(
|
|||||||||
Other debt borrowings including senior notes |
|
|
|||||||||
Other debt repayments |
(
|
(
|
|||||||||
Redemption premiums and repayments of senior notes |
(
|
|
|||||||||
Debt issuance costs |
(
|
|
|||||||||
Cash received from termination of interest rate swap agreements |
|
|
|||||||||
Proceeds from stock option exercises |
|
|
|||||||||
Stock repurchases |
(
|
|
|||||||||
Dividends paid |
(
|
(
|
|||||||||
Other financing activities |
(
|
(
|
|||||||||
Net cash used for financing activities |
(
|
(
|
|||||||||
Effect of exchange rates on cash, cash equivalents and restricted cash |
(
|
|
|||||||||
Net decrease in cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|||||||||
Cash, cash equivalents and restricted cash at end of period | $ |
|
$ |
|
|||||||
Supplemental disclosures of cash flow information: | |||||||||||
Cash paid during the period for: | |||||||||||
Interest | $ |
|
$ |
|
|||||||
Income taxes, net of refunds |
|
|
Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||
(In thousands) | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash
(1)
|
|
|
|||||||||
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows | $ |
|
$ |
|
(1)
|
Restricted cash primarily represents cash and cash equivalents of Sysco’s wholly owned captive insurance subsidiary, restricted for use to secure the insurer’s obligations for workers’ compensation, general liability and auto liability programs. Restricted cash is located within other assets in each consolidated balance sheet.
|
13-Week Period Ended Apr. 2, 2022 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Fresh and frozen meats | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Canned and dry products |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Other sales relate to non-food products, including textiles and amenities for our hotel supply business, equipment, and other janitorial products, medical supplies and smallwares.
|
13-Week Period Ended Mar. 27, 2021 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Fresh and frozen meats | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Canned and dry products |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Other sales relate to non-food products, including textiles and amenities for our hotel supply business, equipment, and other janitorial products, medical supplies and smallwares.
|
39-Week Period Ended Apr. 2, 2022 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Fresh and frozen meats | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Canned and dry products |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Other sales relate to non-food products, including textiles and amenities for our hotel supply business, equipment, and other janitorial products, medical supplies and smallwares.
|
39-Week Period Ended Mar. 27, 2021 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Fresh and frozen meats | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Canned and dry products |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Other sales relate to non-food products, including textiles and amenities for our hotel supply business, equipment and subscription sales for our former Sysco Labs business, and other janitorial products, medical supplies and smallwares.
|
Preliminary Purchase Price Allocation | |||||
(In millions) | |||||
Accounts receivable, net | $ |
|
|||
Inventories |
|
||||
Plant and equipment |
|
||||
Other assets |
|
||||
Goodwill and other intangibles
(1)
|
|
||||
Total assets |
|
||||
Accounts payable |
(
|
||||
Accrued expenses |
(
|
||||
Deferred tax liabilities |
(
|
||||
Other liabilities |
(
|
||||
Total consideration | $ |
|
Assets Measured at Fair Value as of Apr. 2, 2022 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other assets
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Assets Measured at Fair Value as of Jul. 3, 2021 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other assets
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Apr. 2, 2022 | |||||||||||||||||||||||||||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||||||
Corporate bonds | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Government bonds |
|
|
(
|
|
|
|
|||||||||||||||||||||||||||||
Total marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Jul. 3, 2021 | |||||||||||||||||||||||||||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||||||
Corporate bonds | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Government bonds |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Apr. 2, 2022 | |||||
(In thousands) | |||||
Due in one year or less | $ |
|
|||
Due after one year through five years |
|
||||
Due after five years through ten years |
|
||||
Total | $ |
|
Maturity Date of the Hedging Instrument | Currency / Unit of Measure | Notional Value | ||||||||||||
(In millions) | ||||||||||||||
Hedging of interest rate risk | ||||||||||||||
June 2023 | Euro |
|
||||||||||||
Hedging of foreign currency risk | ||||||||||||||
Various (April 2022 to August 2022) | Swedish Krona |
|
||||||||||||
Various (April 2022 to December 2022) | British Pound Sterling |
|
||||||||||||
June 2023 | Euro |
|
||||||||||||
Hedging of fuel risk | ||||||||||||||
Various (April 2022 to July 2023) | Gallons |
|
Derivative Fair Value | |||||||||||||||||
Balance Sheet location | Apr. 2, 2022 | Jul. 3, 2021 | |||||||||||||||
(In thousands) | |||||||||||||||||
Fair Value Hedges: | |||||||||||||||||
Interest rate swaps | Other assets | $ |
|
$ |
|
||||||||||||
Cash Flow Hedges: | |||||||||||||||||
Fuel swaps | Other current assets | $ |
|
$ |
|
||||||||||||
Foreign currency forwards | Other current assets |
|
|
||||||||||||||
Fuel swaps | Other assets |
|
|
||||||||||||||
Fuel swaps | Other current liabilities |
|
|
||||||||||||||
Foreign currency forwards | Other current liabilities |
|
|
||||||||||||||
Fuel swaps | Other long-term liabilities |
|
|
||||||||||||||
13-Week Period Ended | 39-Week Period Ended | |||||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | |||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Total amounts of income and expense line items presented in the consolidated results of operations in which the effects of fair value hedges are recorded | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Gain or (loss) on fair value hedging relationships: | ||||||||||||||||||||||||||
Interest rate swaps: | ||||||||||||||||||||||||||
Hedged items | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
Derivatives designated as hedging instruments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
13-Week Period Ended | 39-Week Period Ended | |||||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | |||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Interest expense | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Decrease in fair value of debt |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Hedged items | $ |
|
$ |
|
$ |
|
$ |
(
|
13-Week Period Ended Apr. 2, 2022 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
|
Operating expense | $ |
|
||||||||||||
Foreign currency contracts |
(
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
|
$ |
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
|
N/A | $ |
|
||||||||||||
Total | $ |
|
$ |
|
|||||||||||||
13-Week Period Ended Mar. 27, 2021 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
|
Operating expense | $ |
(
|
||||||||||||
Foreign currency contracts |
(
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
|
$ |
(
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
|
N/A | $ |
|
||||||||||||
Total | $ |
|
$ |
|
39-Week Period Ended Apr. 2, 2022 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
|
Operating expense | $ |
|
||||||||||||
Foreign currency contracts |
(
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
|
$ |
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
|
N/A | $ |
|
||||||||||||
Total | $ |
|
$ |
|
|||||||||||||
39-Week Period Ended Mar. 27, 2021 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
(
|
Operating expense | $ |
(
|
||||||||||||
Foreign currency contracts |
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
(
|
$ |
(
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign currency contracts | $ |
|
N/A | $ |
|
||||||||||||
Foreign denominated debt |
|
N/A |
|
||||||||||||||
Total | $ |
|
$ |
|
Apr. 2, 2022 | |||||||||||
Carrying Amount of Hedged Assets (Liabilities) | Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Assets (Liabilities) | ||||||||||
(In thousands) | |||||||||||
Balance sheet location: | |||||||||||
Long-term debt | $ |
(
|
$ |
(
|
Jul. 3, 2021 | |||||||||||
Carrying Amount of Hedged Assets (Liabilities) | Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Assets (Liabilities) | ||||||||||
(In thousands) | |||||||||||
Balance sheet location: | |||||||||||
Long-term debt | $ |
(
|
$ |
(
|
Maturity Date |
Par Value
(in millions) |
Coupon Rate |
Pricing
(percentage of par) |
||||||||||||||
December 14, 2031 (the 2031 Notes) | $ |
|
|
% |
|
% | |||||||||||
December 14, 2051 (the 2051 Notes) |
|
|
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||||||||||||
(In thousands, except for share
and per share data) |
(In thousands, except for share
and per share data) |
||||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average basic shares outstanding |
|
|
|
|
|||||||||||||||||||
Dilutive effect of share-based awards |
|
|
|
|
|||||||||||||||||||
Weighted-average diluted shares outstanding |
|
|
|
|
|||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
13-Week Period Ended Apr. 2, 2022 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net | $ |
|
$ |
|
$ |
|
||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A |
(
|
|
(
|
|||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(1)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedge
|
Operating expenses
(2)
|
|
|
|
|||||||||||||||||||
Change in net investment hedge | N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive income before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Total other comprehensive income (loss) | $ |
(
|
$ |
|
$ |
(
|
13-Week Period Ended Mar. 27, 2021 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net | $ |
|
$ |
|
$ |
|
||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A |
|
|
|
|||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(1)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedge |
Operating expenses
(2)
|
|
|
|
|||||||||||||||||||
Change in net investment hedges | N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive income before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Total other comprehensive income | $ |
|
$ |
|
$ |
|
39-Week Period Ended Apr. 2, 2022 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net | $ |
|
$ |
|
$ |
|
||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A |
(
|
|
(
|
|||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(1)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(2)
|
|
|
|
|||||||||||||||||||
Change in net investment hedges | N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive income before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Total other comprehensive income (loss) | $ |
(
|
$ |
|
$ |
(
|
39-Week Period Ended Mar. 27, 2021 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net | $ |
|
$ |
|
$ |
|
||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A |
|
|
|
|||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(1)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedge
(3)
|
Operating expenses
(2)
|
|
|
|
|||||||||||||||||||
Change in net investment hedges | N/A |
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive income before reclassification adjustments |
(
|
(
|
(
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Total other comprehensive (loss) income | $ |
|
$ |
|
$ |
|
39-Week Period Ended Apr. 2, 2022 | |||||||||||||||||||||||||||||
Pension and Other Postretirement Benefit Plans,
net of tax |
Foreign Currency Translation |
Hedging,
net of tax |
Marketable Securities,
net of tax |
Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Jul. 3, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — | — |
|
— |
|
||||||||||||||||||||||||
Change in net investment hedges | — | — |
|
— |
|
||||||||||||||||||||||||
Change in cash flow hedge | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost |
|
— | — | — |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses |
|
— | — | — |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
(
|
(
|
||||||||||||||||||||||||
Balance as of Apr. 2, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
39-Week Period Ended Mar. 27, 2021 | |||||||||||||||||||||||||||||
Pension and Other Postretirement Benefit Plans,
net of tax |
Foreign Currency Translation |
Hedging,
net of tax |
Marketable Securities,
net of tax |
Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Jun. 27, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation | — |
|
— | — |
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — | — |
|
— |
|
||||||||||||||||||||||||
Change in net investment hedges | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
Change in cash flow hedge | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost |
|
— | — | — |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses |
|
— | — | — |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
(
|
(
|
||||||||||||||||||||||||
Balance as of Mar. 27, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||||||||||||
Sales: | (In thousands) | (In thousands) | |||||||||||||||||||||
U.S. Foodservice Operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
International Foodservice Operations |
|
|
|
|
|||||||||||||||||||
SYGMA |
|
|
|
|
|||||||||||||||||||
Other |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||||||||||||
Operating income (loss): | (In thousands) | (In thousands) | |||||||||||||||||||||
U.S. Foodservice Operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
International Foodservice Operations |
|
(
|
|
(
|
|||||||||||||||||||
SYGMA |
|
|
(
|
|
|||||||||||||||||||
Other |
(
|
|
|
|
|||||||||||||||||||
Total segments |
|
|
|
|
|||||||||||||||||||
Global Support Center |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total operating income |
|
|
|
|
|||||||||||||||||||
Interest expense |
|
|
|
|
|||||||||||||||||||
Other (income) expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Earnings before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Apr. 2, 2022 | Mar. 27, 2021 | Apr. 2, 2022 | Mar. 27, 2021 | ||||||||||||||||||||
Sales | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
Cost of sales | 82.2 | 82.0 | 82.1 | 81.7 | |||||||||||||||||||
Gross profit | 17.8 | 18.0 | 17.9 | 18.3 | |||||||||||||||||||
Operating expenses | 14.9 | 16.0 | 14.7 | 15.8 | |||||||||||||||||||
Operating income | 2.9 | 2.0 | 3.2 | 2.5 | |||||||||||||||||||
Interest expense | 0.7 | 1.2 | 1.0 | 1.2 | |||||||||||||||||||
Other (income) expense, net | (0.1) | (0.1) | — | — | |||||||||||||||||||
Earnings before income taxes | 2.3 | 0.9 | 2.2 | 1.3 | |||||||||||||||||||
Income taxes | 0.5 | 0.1 | 0.5 | 0.2 | |||||||||||||||||||
Net earnings | 1.8 | % | 0.8 | % | 1.7 | % | 1.1 | % |
13-Week Period Ended | 39-Week Period Ended | ||||||||||
Apr. 2, 2022 | Apr. 2, 2022 | ||||||||||
Sales | 42.9 | % | 41.3 | % | |||||||
Cost of sales | 43.2 | 42.1 | |||||||||
Gross profit | 42.0 | 37.8 | |||||||||
Operating expenses | 33.4 | 31.0 | |||||||||
Operating income | 110.1 | 81.2 | |||||||||
Interest expense | (14.9) | 12.8 | |||||||||
Other (income) expense, net
(1) (2)
|
8.4 | 95.9 | |||||||||
Earnings before income taxes | 274.8 | 149.6 | |||||||||
Income taxes | 490.0 | 268.0 | |||||||||
Net earnings | 241.1 | % | 127.5 | % | |||||||
Basic earnings per share | 252.9 | % | 127.4 | % | |||||||
Diluted earnings per share | 247.1 | 126.0 | |||||||||
Average shares outstanding | (0.5) | 0.1 | |||||||||
Diluted shares outstanding | (0.5) | 0.3 |
13-Week Period Ended Apr. 2, 2022 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 12,006,163 | $ | 2,834,089 | $ | 1,794,837 | $ | 267,050 | $ | — | $ | 16,902,139 | |||||||||||||||||||||||
Sales increase (decrease) | 43.6 | % | 64.5 | % | 13.5 | % | 66.4 | % | 42.9 | % | |||||||||||||||||||||||||
Percentage of total | 71.0 | % | 16.8 | % | 10.6 | % | 1.5 | % | 99.9 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 746,467 | $ | 7,760 | $ | 4,362 | $ | (3,972) | $ | (258,888) | $ | 495,729 | |||||||||||||||||||||||
Operating income (loss) increase (decrease) | 36.8 | % | NM | (66.3) | % | NM | 25.1 | % | NM | ||||||||||||||||||||||||||
Percentage of total segments | 98.9 | % | 1.0 | % | 0.6 | % | (0.5) | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) as a percentage of sales | 6.2 | % | 0.3 | % | 0.2 | % | (1.5) | % | 2.9 | % |
13-Week Period Ended Mar. 27, 2021 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 8,360,241 | $ | 1,723,126 | $ | 1,580,695 | $ | 160,527 | $ | — | $ | 11,824,589 | |||||||||||||||||||||||
Percentage of total | 70.7 | % | 14.6 | % | 13.4 | % | 1.3 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 545,502 | $ | (121,487) | $ | 12,937 | $ | 5,884 | $ | (206,919) | $ | 235,917 | |||||||||||||||||||||||
Percentage of total segments | 123.2 | % | (27.4) | % | 2.9 | % | 1.3 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.5 | % | (7.1) | % | 0.8 | % | 3.7 | % | 2.0 | % |
39-Week Period Ended Apr. 2, 2022 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 35,107,281 | $ | 8,535,608 | $ | 5,270,193 | $ | 765,806 | $ | — | $ | 49,678,888 | |||||||||||||||||||||||
Sales increase (decrease) | 45.0 | % | 45.8 | % | 13.9 | % | 61.2 | % | 41.3 | % | |||||||||||||||||||||||||
Percentage of total | 70.7 | % | 17.2 | % | 10.6 | % | 1.5 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 2,220,812 | $ | 55,181 | $ | (4,814) | $ | 2,667 | $ | (701,526) | $ | 1,572,320 | |||||||||||||||||||||||
Operating income increase (decrease) | 37.2 | % | 127.3 | % | (113.4) | % | (45.1) | % | 81.2 | % | |||||||||||||||||||||||||
Percentage of total segments | 97.7 | % | 2.4 | % | (0.2) | % | 0.1 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.3 | % | 0.6 | % | (0.1) | % | 0.3 | % | 3.2 | % |
39-Week Period Ended Mar. 27, 2021 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 24,205,917 | $ | 5,854,608 | $ | 4,625,244 | $ | 475,181 | $ | — | $ | 35,160,950 | |||||||||||||||||||||||
Percentage of total | 68.8 | % | 16.7 | % | 13.2 | % | 1.3 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 1,619,162 | $ | (201,973) | $ | 35,957 | $ | 4,861 | $ | (590,449) | $ | 867,558 | |||||||||||||||||||||||
Percentage of total segments | 111.1 | % | (13.9) | % | 2.5 | % | 0.3 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.7 | % | (3.4) | % | 0.8 | % | 1.0 | % | 2.5 | % |
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 12,006,163 | $ | 8,360,241 | $ | 3,645,922 | 43.6 | % | |||||||||||||||
Gross profit | 2,270,045 | 1,634,837 | 635,208 | 38.9 | |||||||||||||||||||
Operating expenses | 1,523,578 | 1,089,335 | 434,243 | 39.9 | |||||||||||||||||||
Operating income | $ | 746,467 | $ | 545,502 | $ | 200,965 | 36.8 | % | |||||||||||||||
Gross profit | $ | 2,270,045 | $ | 1,634,837 | $ | 635,208 | 38.9 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 1,520,676 | 1,109,719 | 410,957 | 37.0 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 749,369 | $ | 525,118 | $ | 224,251 | 42.7 | % | |||||||||||||||
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 35,107,281 | $ | 24,205,917 | $ | 10,901,364 | 45.0 | % | |||||||||||||||
Gross profit | 6,594,477 | 4,793,866 | 1,800,611 | 37.6 | |||||||||||||||||||
Operating expenses | 4,373,665 | 3,174,704 | 1,198,961 | 37.8 | |||||||||||||||||||
Operating income | $ | 2,220,812 | $ | 1,619,162 | $ | 601,650 | 37.2 | % | |||||||||||||||
Gross profit | $ | 6,594,477 | $ | 4,793,866 | $ | 1,800,611 | 37.6 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 4,364,629 | 3,293,919 | 1,070,710 | 32.5 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 2,229,848 | $ | 1,499,947 | $ | 729,901 | 48.7 | % |
Increase (Decrease) | Increase (Decrease) | ||||||||||||||||||||||
13-Week Period | 39-Week Period | ||||||||||||||||||||||
(Dollars in millions) | (Dollars in millions) | ||||||||||||||||||||||
Cause of change | Percentage | Dollars | Percentage | Dollars | |||||||||||||||||||
Case volume | 20.0 | % | $ | 1,668.1 | 23.0 | % | $ | 5,568.0 | |||||||||||||||
Inflation
(1)
|
16.7 | 1,392.0 | 15.3 | 3,692.1 | |||||||||||||||||||
Acquisitions
(2)
|
4.5 | 373.6 | 3.4 | 832.9 | |||||||||||||||||||
Other
(3)
|
2.4 | 212.2 | 3.3 | 808.4 | |||||||||||||||||||
Total change in sales | 43.6 | % | $ | 3,645.9 | 45.0 | % | $ | 10,901.4 | |||||||||||||||
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 2,834,089 | $ | 1,723,126 | $ | 1,110,963 | 64.5 | % | |||||||||||||||
Gross profit | 570,241 | 325,200 | 245,041 | 75.4 | |||||||||||||||||||
Operating expenses | 562,481 | 446,687 | 115,794 | 25.9 | |||||||||||||||||||
Operating income (loss) | $ | 7,760 | $ | (121,487) | $ | 129,247 | 106.4 | % | |||||||||||||||
Gross profit | $ | 570,241 | $ | 325,200 | $ | 245,041 | 75.4 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 535,617 | 417,575 | 118,042 | 28.3 | |||||||||||||||||||
Adjusted operating income (loss) (Non-GAAP) | $ | 34,624 | $ | (92,375) | $ | 126,999 | 137.5 | % | |||||||||||||||
Sales on a constant currency basis (Non-GAAP) | $ | 2,917,767 | $ | 1,723,126 | $ | 1,194,641 | 69.3 | % | |||||||||||||||
Gross profit on a constant currency basis (Non-GAAP) | 590,595 | 325,200 | 265,395 | 81.6 | |||||||||||||||||||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 555,721 | 417,575 | 138,146 | 33.1 | |||||||||||||||||||
Adjusted operating income (loss) (Non-GAAP) | $ | 34,874 | $ | (92,375) | $ | 127,249 | 137.8 | % | |||||||||||||||
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 8,535,608 | $ | 5,854,608 | $ | 2,681,000 | 45.8 | % | |||||||||||||||
Gross profit | 1,725,306 | 1,149,438 | 575,868 | 50.1 | |||||||||||||||||||
Operating expenses | 1,670,125 | 1,351,411 | 318,714 | 23.6 | |||||||||||||||||||
Operating (loss) income | $ | 55,181 | $ | (201,973) | $ | 257,154 | 127.3 | % | |||||||||||||||
Gross profit | $ | 1,725,306 | $ | 1,149,438 | $ | 575,868 | 50.1 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 1,586,914 | 1,278,247 | 308,667 | 24.1 | |||||||||||||||||||
Adjusted operating (loss) income (Non-GAAP) | $ | 138,392 | $ | (128,809) | $ | 267,201 | 207.4 | % | |||||||||||||||
Sales on a constant currency basis (Non-GAAP) | $ | 8,463,829 | $ | 5,854,608 | $ | 2,609,221 | 44.6 | % | |||||||||||||||
Gross profit on a constant currency basis (Non-GAAP) | 1,718,893 | 1,149,438 | 569,455 | 49.5 | |||||||||||||||||||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 1,582,750 | 1,278,247 | 304,503 | 23.8 | |||||||||||||||||||
Adjusted operating (loss) income on a constant currency basis (Non-GAAP) | $ | 136,143 | $ | (128,809) | $ | 264,952 | 205.7 | % |
Increase (Decrease) | Increase (Decrease) | ||||||||||||||||||||||
13-Week Period | 39-Week Period | ||||||||||||||||||||||
(Dollars in millions) | (Dollars in millions) | ||||||||||||||||||||||
Cause of change | Percentage | Dollars | Percentage | Dollars | |||||||||||||||||||
Inflation | 7.9 | % | $ | 136.1 | 7.5 | % | $ | 440.0 | |||||||||||||||
Foreign currency | (4.9) | (83.8) | 1.3 | 74.0 | |||||||||||||||||||
Other
(1)
|
61.5 | 1,058.7 | 37.0 | 2,167.0 | |||||||||||||||||||
Total change in sales | 64.5 | % | $ | 1,111.0 | 45.8 | % | $ | 2,681.0 | |||||||||||||||
Our discussion of our results includes certain non-GAAP financial measures, including EBITDA and adjusted EBITDA, that we believe provide important perspective with respect to underlying business trends. Other than free cash flow, any non-GAAP financial measures will be denoted as adjusted measures to remove the impact of restructuring and transformational project costs consisting of: (1) restructuring charges, (2) expenses associated with our various transformation initiatives and (3) facility closure and severance charges; acquisition-related costs consisting of: (1) intangible amortization expense and (2) acquisition costs and due diligence costs related to our acquisitions; and the reduction of bad debt expense previously recognized in fiscal 2020 due to the impact of the COVID-19 pandemic on the collectability of our pre-pandemic trade receivable balances. Our results for fiscal 2022 were also impacted by: (1) a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory, (2) debt extinguishment costs and (3) the increase in reserves for uncertain tax positions. Our results for the first 39 weeks of fiscal 2021 were also impacted by losses on the sale of businesses.
|
||
The results of our foreign operations can be impacted due to changes in exchange rates applicable in converting local currencies to U.S. dollars. We measure our total Sysco and our International Foodservice Operations results on a constant currency basis. Constant currency operating results are calculated by translating current-period local currency operating results with the currency exchange rates used to translate the financial statements in the comparable prior-year period to determine what the current-period U.S. dollar operating results would have been if the currency exchange rate had not changed from the comparable prior-year period. | ||
Management believes that adjusting its operating expenses, operating income, net earnings and diluted earnings per share to remove these Certain Items and presenting its International Foodservice Operations results on a constant currency basis, provides an important perspective with respect to our underlying business trends and results and provides meaningful supplemental information to both management and investors that (1) is indicative of the performance of the company’s underlying operations and (2) facilitates comparisons on a year-over-year basis. | ||
Sysco has a history of growth through acquisitions and excludes from its non-GAAP financial measures the impact of acquisition-related intangible amortization, acquisition costs and due-diligence costs for those acquisitions. We believe this approach significantly enhances the comparability of Sysco’s results for fiscal 2022 and fiscal 2021. | ||
Set forth below is a reconciliation of sales, operating expenses, operating income, other (income) expense, net earnings and diluted earnings per share to adjusted results for these measures for the periods presented. Individual components of diluted earnings per share may not add up to the total presented due to rounding. Adjusted diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. |
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
Sales (GAAP) | $ | 16,902,139 | $ | 11,824,589 | $ | 5,077,550 | 42.9 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
83,760 | — | 83,760 | 0.7 | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 16,985,899 | $ | 11,824,589 | $ | 5,161,310 | 43.6 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 13,888,745 | $ | 9,701,921 | $ | 4,186,824 | 43.2 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
(29,550) | — | (29,550) | (0.3) | |||||||||||||||||||
Cost of sales adjusted for Certain Items (Non-GAAP) | $ | 13,859,195 | $ | 9,701,921 | $ | 4,157,274 | 42.9 | % | |||||||||||||||
Gross profit (GAAP) | $ | 3,013,394 | $ | 2,122,668 | $ | 890,726 | 42.0 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
29,550 | — | 29,550 | 1.4 | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items (Non-GAAP) | 3,042,944 | 2,122,668 | 920,276 | 43.4 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
20,426 | — | 20,426 | 0.9 | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 3,063,370 | $ | 2,122,668 | $ | 940,702 | 44.3 | % | |||||||||||||||
Gross margin (GAAP) | 17.83 | % | 17.95 | % | -12 bps | ||||||||||||||||||
Impact of inventory valuation adjustment
(2)
|
0.17 | — | 17 bps | ||||||||||||||||||||
Comparable Gross margin adjusted for Certain Items (Non-GAAP) | 18.00 | % | 17.95 | % | 5 bps | ||||||||||||||||||
Impact of currency fluctuations
(1)
|
0.03 | — | 3 bps | ||||||||||||||||||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 18.03 | % | 17.95 | % | 8 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 2,517,665 | $ | 1,886,751 | $ | 630,914 | 33.4 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
(19,171) | (34,953) | 15,782 | 45.2 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
(36,699) | (18,834) | (17,865) | (94.9) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
5,717 | 33,473 | (27,756) | (82.9) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 2,467,512 | 1,866,437 | 601,075 | 32.2 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
21,006 | — | 21,006 | 1.1 | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 2,488,518 | $ | 1,866,437 | $ | 622,081 | 33.3 | % | |||||||||||||||
Operating income (GAAP) | $ | 495,729 | $ | 235,917 | $ | 259,812 | 110.1 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
19,171 | 34,953 | (15,782) | (45.2) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
36,699 | 18,834 | 17,865 | 94.9 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
(5,717) | (33,473) | 27,756 | 82.9 | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 575,432 | 256,231 | 319,201 | 124.6 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(581) | — | (581) | (0.2) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 574,851 | $ | 256,231 | $ | 318,620 | 124.4 | % | |||||||||||||||
Other income (GAAP) | $ | (13,777) | $ | (12,708) | $ | (1,069) | (8.4) | % | |||||||||||||||
Impact of loss on sale of business | — | (10,790) | 10,790 | NM | |||||||||||||||||||
Other income adjusted for Certain Items (Non-GAAP) | $ | (13,777) | $ | (23,498) | $ | 9,721 | 41.4 | % | |||||||||||||||
Net earnings (GAAP) | $ | 303,325 | $ | 88,927 | $ | 214,398 | 241.1 | % |
Impact of inventory valuation adjustment
(2)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
19,171 | 34,953 | (15,782) | (45.2) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
36,699 | 18,834 | 17,865 | 94.9 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
(5,717) | (33,473) | 27,756 | 82.9 | |||||||||||||||||||
Impact of loss on sale of business | — | 10,790 | (10,790) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(6)
|
(7,449) | — | (7,449) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(6)
|
(5,579) | (10,300) | 4,721 | 45.8 | |||||||||||||||||||
Tax impact of acquisition-related costs
(6)
|
(8,537) | (5,573) | (2,964) | (53.2) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(6)
|
1,445 | 10,354 | (8,909) | (86.0) | |||||||||||||||||||
Tax impact of loss on sale of business
(6)
|
— | 301 | (301) | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 362,908 | $ | 114,813 | $ | 248,095 | 216.1 | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 0.59 | $ | 0.17 | $ | 0.42 | 247.1 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
0.06 | — | 0.06 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
0.04 | 0.07 | (0.03) | (42.9) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
0.07 | 0.04 | 0.03 | 75.0 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
(0.01) | (0.07) | 0.06 | 85.7 | |||||||||||||||||||
Impact of loss on sale of business | — | 0.02 | (0.02) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(6)
|
(0.01) | — | (0.01) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(6)
|
(0.01) | (0.02) | 0.01 | 50.0 | |||||||||||||||||||
Tax impact of acquisition-related costs
(6)
|
(0.02) | (0.01) | (0.01) | (100.0) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(6)
|
— | 0.02 | (0.02) | NM | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(7)
|
$ | 0.71 | $ | 0.22 | $ | 0.49 | 222.7 | % | |||||||||||||||
(1)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on the current year results.
|
||||
(2)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(3)
|
Fiscal 2022 includes $7 million related to restructuring, severance, and facility closure charges and $12 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy. Fiscal 2021 includes $21 million related to restructuring charges and $14 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy.
|
||||
(4)
|
Fiscal 2022 includes $27 million of intangible amortization expense and $10 million in acquisition and due diligence costs. Fiscal 2021 represents intangible amortization expense.
|
||||
(5)
|
Fiscal 2022 and fiscal 2021 represent the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(6)
|
The tax impact of adjustments for Certain Items are calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.
|
||||
(7)
|
Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. | ||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 30, 2019 | Change in Dollars | % Change | ||||||||||||||||||||
Sales (GAAP) | $ | 16,902,139 | $ | 14,658,074 | $ | 2,244,065 | 15.3 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 13,888,745 | $ | 11,903,776 | $ | 1,984,969 | 16.7 | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
(29,550) | — | (29,550) | (0.3) | |||||||||||||||||||
Cost of sales adjusted for Certain Items (Non-GAAP) | $ | 13,859,195 | $ | 11,903,776 | $ | 1,955,419 | 16.4 | % | |||||||||||||||
Gross profit (GAAP) | $ | 3,013,394 | $ | 2,754,298 | $ | 259,096 | 9.4 | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
29,550 | — | 29,550 | 1.1 | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items (Non-GAAP) | $ | 3,042,944 | $ | 2,754,298 | $ | 288,646 | 10.5 | % | |||||||||||||||
Gross margin (GAAP) | 17.83 | % | 18.79 | % | -96 bps | ||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
0.17 | — | 17 bps | ||||||||||||||||||||
Comparable Gross margin adjusted for Certain Items (Non-GAAP) | 18.00 | % | 18.79 | % | -79 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 2,517,665 | $ | 2,224,713 | $ | 292,952 | 13.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
(19,171) | (72,207) | 53,036 | 73.4 | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
(36,699) | (18,398) | (18,301) | (99.5) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
5,717 | — | 5,717 | NM | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items (Non-GAAP) | $ | 2,467,512 | $ | 2,134,108 | $ | 333,404 | 15.6 | % | |||||||||||||||
Operating income (GAAP) | $ | 495,729 | $ | 529,585 | $ | (33,856) | (6.4) | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
19,171 | 72,207 | (53,036) | (73.4) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
36,699 | 18,398 | 18,301 | 99.5 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(5,717) | — | (5,717) | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 575,432 | $ | 620,190 | $ | (44,758) | (7.2) | % | |||||||||||||||
Net earnings (GAAP) | $ | 303,325 | $ | 440,083 | $ | (136,758) | (31.1) | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
19,171 | 72,207 | (53,036) | (73.4) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
36,699 | 18,398 | 18,301 | 99.5 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(5,717) | — | (5,717) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(5)
|
(7,449) | — | (7,449) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(5)
|
(5,579) | (19,271) | 13,692 | 71.0 | |||||||||||||||||||
Tax impact of acquisition-related costs
(5)
|
(8,537) | (4,899) | (3,638) | (74.3) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(5)
|
1,445 | — | 1,445 | NM | |||||||||||||||||||
Impact of foreign tax credit benefit | — | (95,067) | 95,067 | NM | |||||||||||||||||||
Impact of US transition tax | — | (269) | 269 | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 362,908 | $ | 411,182 | $ | (48,274) | (11.7) | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 0.59 | $ | 0.85 | $ | (0.26) | (30.6) | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
0.06 | — | 0.06 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
0.04 | 0.14 | (0.10) | (71.4) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
0.07 | 0.04 | 0.03 | 75.0 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(0.01) | — | (0.01) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(5)
|
(0.01) | — | (0.01) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(5)
|
(0.01) | (0.04) | 0.03 | 75.0 | |||||||||||||||||||
Tax impact of acquisition-related costs
(5)
|
(0.02) | (0.01) | (0.01) | (100.0) | |||||||||||||||||||
Impact of foreign tax credit benefit | — | (0.18) | 0.18 | NM | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(6)
|
$ | 0.71 | $ | 0.79 | $ | (0.08) | (10.1) | % |
(1)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(2)
|
Fiscal 2022 includes $7 million related to restructuring, severance, and facility closure charges and $12 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy. Fiscal 2019 includes $35 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy and $37 million related to restructuring, facility closure and severance charges. | ||||
(3)
|
Fiscal 2022 includes $27 million of intangible amortization expense and $10 million in acquisition and due diligence costs. Fiscal 2019 includes intangible amortization expense. | ||||
(4)
|
Fiscal 2022 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
The tax impact of adjustments for Certain Items is calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred. | ||||
(6)
|
Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. | ||||
NM represents that the percentage change is not meaningful. |
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
Sales (GAAP) | $ | 49,678,888 | $ | 35,160,950 | $ | 14,517,938 | 41.3 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(77,043) | — | (77,043) | (0.2) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 49,601,845 | $ | 35,160,950 | $ | 14,440,895 | 41.1 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 40,802,636 | $ | 28,719,979 | $ | 12,082,657 | 42.1 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
(29,550) | — | (29,550) | (0.1) | |||||||||||||||||||
Cost of sales adjusted for Certain Items (Non-GAAP) | $ | 40,773,086 | $ | 28,719,979 | $ | 12,053,107 | 42.0 | % | |||||||||||||||
Gross profit (GAAP) | $ | 8,876,252 | $ | 6,440,971 | $ | 2,435,281 | 37.8 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
29,550 | — | 29,550 | 0.5 | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items (Non-GAAP) | 8,905,802 | 6,440,971 | 2,464,831 | 38.3 | % | ||||||||||||||||||
Impact of currency fluctuations
(1)
|
(8,125) | — | (8,125) | (0.2) | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 8,897,677 | $ | 6,440,971 | $ | 2,456,706 | 38.1 | % | |||||||||||||||
Gross margin (GAAP) | 17.87 | % | 18.32 | % | -45 bps | ||||||||||||||||||
Impact of inventory valuation adjustment
(2)
|
0.06 | — | 6 bps | ||||||||||||||||||||
Comparable Gross margin adjusted for Certain Items (Non-GAAP) | 17.93 | % | 18.32 | % | -39 bps | ||||||||||||||||||
Impact of currency fluctuations
(1)
|
0.01 | — | 1 bps | ||||||||||||||||||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 17.94 | % | 18.32 | % | -38 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 7,303,932 | $ | 5,573,413 | $ | 1,730,519 | 31.0 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
(70,058) | (95,078) | 25,020 | 26.3 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
(103,449) | (54,714) | (48,735) | (89.1) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
19,216 | 162,372 | (143,156) | (88.2) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 7,149,641 | $ | 5,585,993 | $ | 1,563,648 | 28.0 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(4,177) | — | (4,177) | (0.1) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 7,145,464 | $ | 5,585,993 | $ | 1,559,471 | 27.9 | % | |||||||||||||||
Operating income (GAAP) | $ | 1,572,320 | $ | 867,558 | $ | 704,762 | 81.2 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
70,058 | 95,078 | (25,020) | (26.3) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
103,449 | 54,714 | 48,735 | 89.1 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
(19,216) | (162,372) | 143,156 | 88.2 | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 1,756,161 | $ | 854,978 | $ | 901,183 | 105.4 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(3,947) | — | (3,947) | (0.5) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 1,752,214 | $ | 854,978 | $ | 897,236 | 104.9 | % | |||||||||||||||
Interest expense (GAAP) | $ | 495,131 | $ | 438,988 | $ | 56,143 | 12.8 | % | |||||||||||||||
Impact of loss on extinguishment of debt | (115,603) | — | (115,603) | NM | |||||||||||||||||||
Interest expense adjusted for Certain Items (Non-GAAP) | $ | 379,528 | $ | 438,988 | $ | (59,460) | (13.5) | % | |||||||||||||||
Other income (GAAP) | $ | (27,705) | $ | (14,140) | $ | (13,565) | (95.9) | % |
Impact of loss on sale of business | — | (22,834) | 22,834 | NM | |||||||||||||||||||
Other income adjusted for Certain Items (Non-GAAP) | $ | (27,705) | $ | (36,974) | $ | 9,269 | 25.1 | % | |||||||||||||||
Net earnings (GAAP) | $ | 848,779 | $ | 373,116 | $ | 475,663 | 127.5 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
70,058 | 95,078 | (25,020) | (26.3) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
103,449 | 54,714 | 48,735 | 89.1 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
(19,216) | (162,372) | 143,156 | 88.2 | |||||||||||||||||||
Impact of loss on extinguishment of debt | 115,603 | — | 115,603 | NM | |||||||||||||||||||
Impact of loss on sale of business | — | 22,834 | (22,834) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(6)
|
(7,449) | — | (7,449) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(6)
|
(17,661) | (26,886) | 9,225 | 34.3 | |||||||||||||||||||
Tax impact of acquisition-related costs
(6)
|
(26,079) | (15,471) | (10,608) | (68.6) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(6)
|
4,844 | 45,913 | (41,069) | (89.4) | |||||||||||||||||||
Tax impact of loss on extinguishment of debt
(6)
|
(29,143) | — | (29,143) | NM | |||||||||||||||||||
Tax impact of loss on sale of business
(6)
|
— | (7,251) | 7,251 | NM | |||||||||||||||||||
Impact of adjustments to uncertain tax positions | 12,000 | — | 12,000 | NM | |||||||||||||||||||
Impact of foreign tax rate change | — | (5,548) | 5,548 | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 1,084,735 | $ | 374,127 | $ | 710,608 | 189.9 | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 1.65 | $ | 0.73 | $ | 0.92 | 126.0 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
0.06 | — | 0.06 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
0.14 | 0.19 | (0.05) | (26.3) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
0.20 | 0.11 | 0.09 | 81.8 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
(0.04) | (0.32) | 0.28 | 87.5 | |||||||||||||||||||
Impact of loss on extinguishment of debt | 0.22 | — | 0.22 | NM | |||||||||||||||||||
Impact of loss on sale of business | — | 0.04 | (0.04) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(6)
|
(0.01) | — | (0.01) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(6)
|
(0.03) | (0.05) | 0.02 | 40.0 | |||||||||||||||||||
Tax impact of acquisition-related costs
(6)
|
(0.05) | (0.03) | (0.02) | (66.7) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(6)
|
0.01 | 0.09 | (0.08) | (88.9) | |||||||||||||||||||
Tax impact of loss on extinguishment of debt
(6)
|
(0.06) | — | (0.06) | NM | |||||||||||||||||||
Tax impact of loss on sale of business
(6)
|
— | (0.01) | 0.01 | NM | |||||||||||||||||||
Impact of adjustments to uncertain tax positions | 0.02 | — | 0.02 | NM | |||||||||||||||||||
Impact of foreign tax rate change | — | (0.01) | 0.01 | NM | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(7)
|
$ | 2.11 | $ | 0.73 | $ | 1.38 | 189.0 | % |
(1)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on the current year results.
|
||||
(2)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(3)
|
Fiscal 2022 includes $39 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy and $31 million related to restructuring charges, severance and facility closure charges. Fiscal 2021 includes $56 million related to restructuring, severance and facility closure charges, and $39 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy.
|
||||
(4)
|
Fiscal 2022 includes $75 million of intangible amortization expense and $28 million in acquisition and due diligence costs. Fiscal 2021 represents intangible amortization expense.
|
||||
(5)
|
Fiscal 2022 and fiscal 2021 represent the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020.
|
||||
(6)
|
The tax impact of adjustments for Certain Items is calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.
|
||||
(7)
|
Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding.
|
||||
NM represents that the percentage change is not meaningful. |
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 30, 2019 | Change in Dollars | % Change | ||||||||||||||||||||
Sales (GAAP) | $ | 49,678,888 | $ | 44,639,060 | $ | 5,039,828 | 11.3 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 40,802,636 | $ | 36,209,265 | $ | 4,593,371 | 12.7 | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
(29,550) | — | (29,550) | NM | |||||||||||||||||||
Cost of sales adjusted for Certain Items (Non-GAAP) | $ | 40,773,086 | $ | 36,209,265 | $ | 4,563,821 | 12.6 | % | |||||||||||||||
Gross profit (GAAP) | $ | 8,876,252 | $ | 8,429,795 | $ | 446,457 | 5.3 | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items (Non-GAAP) | $ | 8,905,802 | $ | 8,429,795 | $ | 476,007 | 5.7 | % | |||||||||||||||
Gross margin (GAAP) | 17.87 | % | 18.88 | % | -101 bps | ||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
0.06 | — | 6 bps | ||||||||||||||||||||
Comparable Gross margin adjusted for Certain Items (Non-GAAP) | 17.93 | % | 18.88 | % | -95 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 7,303,932 | $ | 6,820,175 | $ | 483,757 | 7.1 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
(70,058) | (247,547) | 177,489 | 71.7 | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
(103,449) | (58,042) | (45,407) | (78.2) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
19,216 | — | 19,216 | NM | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items (Non-GAAP) | $ | 7,149,641 | $ | 6,514,586 | $ | 635,055 | 9.7 | % | |||||||||||||||
Operating income (GAAP) | $ | 1,572,320 | $ | 1,609,620 | $ | (37,300) | (2.3) | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
70,058 | 247,547 | (177,489) | (71.7) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
103,449 | 58,042 | 45,407 | 78.2 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(19,216) | — | (19,216) | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 1,756,161 | $ | 1,915,209 | $ | (159,048) | (8.3) | % | |||||||||||||||
Interest expense (GAAP) | $ | 495,131 | $ | 270,643 | $ | 224,488 | 82.9 | % | |||||||||||||||
Impact of loss on extinguishment of debt | (115,603) | — | (115,603) | NM | |||||||||||||||||||
Interest expense adjusted for Certain Items (Non-GAAP) | $ | 379,528 | $ | 270,643 | $ | 108,885 | 40.2 | % | |||||||||||||||
Net earnings (GAAP) | $ | 848,779 | $ | 1,138,505 | $ | (289,726) | (25.4) | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
70,058 | 247,547 | (177,489) | (71.7) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
103,449 | 58,042 | 45,407 | 78.2 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(19,216) | — | (19,216) | NM | |||||||||||||||||||
Impact of loss on extinguishment of debt | 115,603 | — | 115,603 | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(5)
|
(7,449) | — | (7,449) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(5)
|
(17,661) | (64,831) | 47,170 | 72.8 | |||||||||||||||||||
Tax impact of acquisition-related costs
(5)
|
(26,079) | (15,201) | (10,878) | (71.6) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(5)
|
4,844 | — | 4,844 | NM | |||||||||||||||||||
Tax impact of loss on extinguishment of debt
(5)
|
(29,143) | — | (29,143) | NM | |||||||||||||||||||
Impact of foreign tax credit benefit | — | (95,067) | 95,067 | NM |
Impact of adjustments to uncertain tax positions | 12,000 | — | 12,000 | NM | |||||||||||||||||||
Impact of US transition tax | — | 14,885 | (14,885) | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 1,084,735 | $ | 1,283,880 | $ | (199,145) | (15.5) | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 1.65 | $ | 2.17 | $ | (0.52) | (24.0) | % | |||||||||||||||
Impact of inventory valuation adjustment
(1)
|
0.06 | — | 0.06 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
0.14 | 0.47 | (0.33) | (70.2) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
0.20 | 0.11 | 0.09 | 81.8 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(0.04) | — | (0.04) | NM | |||||||||||||||||||
Impact of loss on extinguishment of debt | 0.22 | — | 0.22 | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(5)
|
(0.01) | — | (0.01) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(5)
|
(0.03) | (0.12) | 0.09 | 75.0 | |||||||||||||||||||
Tax impact of acquisition-related costs
(5)
|
(0.05) | (0.03) | (0.02) | (66.7) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(5)
|
0.01 | — | 0.01 | NM | |||||||||||||||||||
Tax impact of loss on extinguishment of debt
(5)
|
(0.06) | — | (0.06) | NM | |||||||||||||||||||
Impact of foreign tax credit benefit | — | (0.18) | 0.18 | NM | |||||||||||||||||||
Impact of adjustments to uncertain tax positions | 0.02 | — | 0.02 | NM | |||||||||||||||||||
Impact of US transition tax | — | 0.03 | (0.03) | NM | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(6)
|
$ | 2.11 | $ | 2.45 | $ | (0.34) | (13.9) | % |
(1)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(2)
|
Fiscal 2022 includes $39 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy and $31 million related to restructuring charges, severance and facility closure charges. Fiscal 2019 includes $114 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy, of which $17 million relates to accelerated depreciation related to software that is being replaced, and $133 million related to severance, restructuring and facility closure charges in Europe, Canada and at our Global Support Center, of which $58 million relates to our France restructuring as part of our integration of Brake France and Davigel into Sysco France. | ||||
(3)
|
Fiscal 2022 includes $75 million of intangible amortization expense and $28 million in acquisition and due diligence costs. Fiscal 2019 includes $57 million of intangible amortization expense and $1 million related to integration costs. | ||||
(4)
|
Fiscal 2022 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
The tax impact of adjustments for Certain Items is calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred. | ||||
(6)
|
Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. | ||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 27, 2021 | Change in Dollars | %/bps Change | ||||||||||||||||||||
U.S. FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 1,523,578 | $ | 1,089,335 | $ | 434,243 | 39.9 | % | |||||||||||||||
Impact of restructuring and transformational project costs | 2,543 | (1,285) | 3,828 | 297.9 | |||||||||||||||||||
Impact of acquisition-related costs
(1)
|
(10,505) | — | (10,505) | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
5,060 | 21,669 | (16,609) | (76.6) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 1,520,676 | $ | 1,109,719 | $ | 410,957 | 37.0 | % | |||||||||||||||
Operating income (GAAP) | $ | 746,467 | $ | 545,502 | $ | 200,965 | 36.8 | % | |||||||||||||||
Impact of restructuring and transformational project costs | (2,543) | 1,285 | (3,828) | (297.9) | |||||||||||||||||||
Impact of acquisition-related costs
(1)
|
10,505 | — | 10,505 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
(5,060) | (21,669) | 16,609 | 76.6 | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 749,369 | $ | 525,118 | $ | 224,251 | 42.7 | % | |||||||||||||||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Sales (GAAP) | $ | 2,834,089 | $ | 1,723,126 | $ | 1,110,963 | 64.5 | % | |||||||||||||||
Impact of currency fluctuations
(3)
|
83,678 | — | 83,678 | 4.8 | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 2,917,767 | $ | 1,723,126 | $ | 1,194,641 | 69.3 | % | |||||||||||||||
Gross profit (GAAP) | $ | 570,241 | $ | 325,200 | $ | 245,041 | 75.4 | % | |||||||||||||||
Impact of currency fluctuations
(3)
|
20,354 | — | 20,354 | 6.2 | |||||||||||||||||||
Comparable gross profit using a constant currency basis (Non-GAAP) | $ | 590,595 | $ | 325,200 | $ | 265,395 | 81.6 | % | |||||||||||||||
Gross margin (GAAP) | 20.12 | % | 18.87 | % | 125 bps | ||||||||||||||||||
Impact of currency fluctuations
(3)
|
0.12 | — | 12 bps | ||||||||||||||||||||
Comparable gross margin using a constant currency basis (Non-GAAP) | 20.24 | % | 18.87 | % | 137 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 562,481 | $ | 446,687 | $ | 115,794 | 25.9 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(4)
|
(9,379) | (18,635) | 9,256 | 49.7 | |||||||||||||||||||
Impact of acquisition-related costs
(5)
|
(18,142) | (18,834) | 692 | 3.7 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
657 | 8,357 | (7,700) | (92.1) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 535,617 | 417,575 | 118,042 | 28.3 | |||||||||||||||||||
Impact of currency fluctuations
(3)
|
20,104 | — | 20,104 | 4.8 | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 555,721 | $ | 417,575 | $ | 138,146 | 33.1 | % | |||||||||||||||
Operating income (loss) (GAAP) | $ | 7,760 | $ | (121,487) | $ | 129,247 | 106.4 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(4)
|
9,379 | 18,635 | (9,256) | (49.7) | |||||||||||||||||||
Impact of acquisition-related costs
(5)
|
18,142 | 18,834 | (692) | (3.7) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
(657) | (8,357) | 7,700 | 92.1 | |||||||||||||||||||
Operating income (loss) adjusted for Certain Items (Non-GAAP) | 34,624 | (92,375) | 126,999 | 137.5 | |||||||||||||||||||
Impact of currency fluctuations
(3)
|
250 | — | 250 | 0.3 | |||||||||||||||||||
Comparable operating income (loss) adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 34,874 | $ | (92,375) | $ | 127,249 | 137.8 | % | |||||||||||||||
SYGMA | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 142,883 | $ | 120,541 | $ | 22,342 | 18.5 | % | |||||||||||||||
Operating income (GAAP) | 4,362 | 12,937 | (8,575) | (66.3) | |||||||||||||||||||
OTHER | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 59,369 | $ | 32,027 | $ | 27,342 | 85.4 | % | |||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
— | 3,447 | (3,447) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 59,369 | $ | 35,474 | $ | 23,895 | 67.4 | % | |||||||||||||||
Operating (loss) income (GAAP) | $ | (3,972) | $ | 5,884 | $ | (9,856) | (167.5) | % | |||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
— | (3,447) | 3,447 | NM | |||||||||||||||||||
Operating (loss) income adjusted for Certain Items (Non-GAAP) | $ | (3,972) | $ | 2,437 | $ | (6,409) | (263.0) | % | |||||||||||||||
GLOBAL SUPPORT CENTER | |||||||||||||||||||||||
Gross loss (GAAP) | $ | (29,534) | $ | (8,758) | $ | (20,776) | (237.2) | % | |||||||||||||||
Impact of inventory valuation adjustment
(6)
|
29,550 | — | 29,550 | 337.4 | |||||||||||||||||||
Comparable gross profit (loss) adjusted for Certain Items (Non-GAAP) | $ | 16 | $ | (8,758) | $ | 8,774 | 100.2 | % | |||||||||||||||
Operating expenses (GAAP) | $ | 229,354 | $ | 198,161 | $ | 31,193 | 15.7 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
(12,335) | (15,033) | 2,698 | 17.9 | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
(8,052) | — | (8,052) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 208,967 | $ | 183,128 | $ | 25,839 | 14.1 | % | |||||||||||||||
Operating loss (GAAP) | $ | (258,888) | $ | (206,919) | $ | (51,969) | (25.1) | % | |||||||||||||||
Impact of inventory valuation adjustment
(6)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
12,335 | 15,033 | (2,698) | (17.9) | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
8,052 | — | 8,052 | NM | |||||||||||||||||||
Operating loss adjusted for Certain Items (Non-GAAP) | $ | (208,951) | $ | (191,886) | $ | (17,065) | (8.9) | % | |||||||||||||||
(1)
|
Fiscal 2022 includes intangible amortization expense and acquisition costs. | ||||
(2)
|
Fiscal 2022 and fiscal 2021 represent the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(3)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results. | ||||
(4)
|
Includes restructuring and facility closure costs primarily in Europe. | ||||
(5)
|
Represents intangible amortization expense.
|
||||
(6)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(7)
|
Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy. | ||||
(8)
|
Represents due diligence costs. | ||||
NM represents that the percentage change is not meaningful. |
U.S. FOODSERVICE OPERATIONS | 39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | |||||||||||||||||||
Operating expenses (GAAP) | $ | 4,373,665 | $ | 3,174,704 | $ | 1,198,961 | 37.8 | % | |||||||||||||||
Impact of restructuring and transformational project costs | (383) | (4,010) | 3,627 | 90.4 | |||||||||||||||||||
Impact of acquisition-related costs
(1)
|
(25,382) | — | (25,382) | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
16,729 | 123,225 | (106,496) | (86.4) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 4,364,629 | $ | 3,293,919 | $ | 1,070,710 | 32.5 | % | |||||||||||||||
Operating income (GAAP) | $ | 2,220,812 | $ | 1,619,162 | $ | 601,650 | 37.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs | 383 | 4,010 | (3,627) | (90.4) | |||||||||||||||||||
Impact of acquisition-related costs
(1)
|
25,382 | — | 25,382 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
(16,729) | (123,225) | 106,496 | 86.4 | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 2,229,848 | $ | 1,499,947 | $ | 729,901 | 48.7 | % | |||||||||||||||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Sales (GAAP) | $ | 8,535,608 | $ | 5,854,608 | $ | 2,681,000 | 45.8 | % | |||||||||||||||
Impact of currency fluctuations
(3)
|
(71,779) | — | (71,779) | (1.2) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 8,463,829 | $ | 5,854,608 | $ | 2,609,221 | 44.6 | % | |||||||||||||||
Gross profit (GAAP) | $ | 1,725,306 | $ | 1,149,438 | $ | 575,868 | 50.1 | % | |||||||||||||||
Impact of currency fluctuations
(3)
|
(6,413) | — | (6,413) | (0.6) | |||||||||||||||||||
Comparable gross profit using a constant currency basis (Non-GAAP) | $ | 1,718,893 | $ | 1,149,438 | $ | 569,455 | 49.5 | % | |||||||||||||||
Gross margin (GAAP) | 20.21 | % | 19.63 | % | 58 bps | ||||||||||||||||||
Impact of currency fluctuations
(3)
|
0.10 | — | 10 bps | ||||||||||||||||||||
Comparable gross margin using a constant currency basis (Non-GAAP) | 20.31 | % | 19.63 | % | 68 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 1,670,125 | $ | 1,351,411 | $ | 318,714 | 23.6 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(4)
|
(30,426) | (52,033) | 21,607 | 41.5 | |||||||||||||||||||
Impact of acquisition-related costs
(5)
|
(55,273) | (54,714) | (559) | (1.0) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
2,488 | 33,583 | (31,095) | (92.6) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 1,586,914 | 1,278,247 | 308,667 | 24.1 | |||||||||||||||||||
Impact of currency fluctuations
(3)
|
(4,164) | — | (4,164) | (0.3) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 1,582,750 | $ | 1,278,247 | $ | 304,503 | 23.8 | % | |||||||||||||||
Operating income (loss) (GAAP) | $ | 55,181 | $ | (201,973) | $ | 257,154 | 127.3 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(4)
|
30,426 | 52,033 | (21,607) | (41.5) | |||||||||||||||||||
Impact of acquisition-related costs
(5)
|
55,273 | 54,714 | 559 | 1.0 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
(2,488) | (33,583) | 31,095 | 92.6 | |||||||||||||||||||
Operating income (loss) adjusted for Certain Items (Non-GAAP) | 138,392 | (128,809) | 267,201 | 207.4 | |||||||||||||||||||
Impact of currency fluctuations
(3)
|
(2,249) | — | (2,249) | NM | |||||||||||||||||||
Comparable operating income (loss) adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 136,143 | $ | (128,809) | $ | 264,952 | 205.7 | % | |||||||||||||||
SYGMA | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 427,168 | $ | 358,361 | $ | 68,807 | 19.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs | — | (7) | 7 | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 427,168 | $ | 358,354 | $ | 68,814 | 19.2 | % | |||||||||||||||
Operating (loss) income (GAAP) | $ | (4,814) | $ | 35,957 | $ | (40,771) | (113.4) | % | |||||||||||||||
Impact of restructuring and transformational project costs | — | 7 | (7) | NM | |||||||||||||||||||
Operating (loss) income adjusted for Certain Items (Non-GAAP) | $ | (4,814) | $ | 35,964 | $ | (40,778) | (113.4) | % | |||||||||||||||
OTHER | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 166,560 | $ | 109,247 | $ | 57,313 | 52.5 | % | |||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
(1) | 5,564 | (5,565) | (100.0) | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 166,559 | $ | 114,811 | $ | 51,748 | 45.1 | % | |||||||||||||||
Operating (loss) income (GAAP) | $ | 2,667 | $ | 4,861 | $ | (2,194) | (45.1) | % | |||||||||||||||
Impact of bad debt reserve adjustments
(2)
|
1 | (5,564) | 5,565 | 100.0 | |||||||||||||||||||
Operating (loss) income adjusted for Certain Items (Non-GAAP) | $ | 2,668 | $ | (703) | $ | 3,371 | NM | ||||||||||||||||
GLOBAL SUPPORT CENTER | |||||||||||||||||||||||
Gross loss (GAAP) | $ | (35,112) | $ | (10,759) | $ | (24,353) | (226.4) | % | |||||||||||||||
Impact of inventory valuation adjustment
(6)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Comparable gross profit (loss) adjusted for Certain Items (Non-GAAP) | $ | (5,562) | $ | (10,759) | $ | 5,197 | 48.3 | % | |||||||||||||||
Operating expenses (GAAP) | $ | 666,414 | $ | 579,690 | $ | 86,724 | 15.0 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
(39,249) | (39,028) | (221) | (0.6) | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
(22,794) | — | (22,794) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 604,371 | $ | 540,662 | $ | 63,709 | 11.8 | % | |||||||||||||||
Operating loss (GAAP) | $ | (701,526) | $ | (590,449) | $ | (111,077) | (18.8) | % | |||||||||||||||
Impact of inventory valuation adjustment
(6)
|
29,550 | — | 29,550 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
39,249 | 39,028 | 221 | 0.6 | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
22,794 | — | 22,794 | NM | |||||||||||||||||||
Operating loss adjusted for Certain Items (Non-GAAP) | $ | (609,933) | $ | (551,421) | $ | (58,512) | (10.6) | % |
(1)
|
Fiscal 2022 includes intangible amortization expense and acquisition costs. | ||||
(2)
|
Fiscal 2022 and fiscal 2021 represent the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020.
|
||||
(3)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results.
|
||||
(4)
|
Includes restructuring, severance and facility closure costs primarily in Europe.
|
||||
(5)
|
Represents intangible amortization expense.
|
||||
(6)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(7)
|
Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy.
|
||||
(8)
|
Represents due diligence costs.
|
||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 303,325 | $ | 88,927 | $ | 214,398 | 241.1 | % | |||||||||||||||
Interest (GAAP) | 124,018 | 145,773 | (21,755) | (14.9) | |||||||||||||||||||
Income taxes (GAAP) | 82,163 | 13,925 | 68,238 | NM | |||||||||||||||||||
Depreciation and amortization (GAAP) | 193,843 | 177,139 | 16,704 | 9.4 | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 703,349 | $ | 425,764 | $ | 277,585 | 65.2 | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
$ | 29,550 | $ | — | $ | 29,550 | NM | ||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
18,746 | 34,301 | (15,555) | (45.3) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
9,861 | — | 9,861 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(5,717) | (33,473) | 27,756 | 82.9 | |||||||||||||||||||
Impact of loss on sale of business | — | 10,790 | (10,790) | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP)
(5)
|
$ | 755,789 | $ | 437,382 | $ | 318,407 | 72.8 | % |
(1)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(2)
|
Fiscal 2022 and fiscal 2021 include charges related to restructuring, severance, and facility closures, as well as various transformation initiative costs, primarily consisting of changes to our business technology strategy, excluding charges related to accelerated depreciation.
|
||||
(3)
|
Fiscal 2022 includes acquisition and due diligence costs. | ||||
(4)
|
Fiscal 2022 and fiscal 2021 represent the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $2 million and $5 million for fiscal 2022 and fiscal 2021, respectively, or non-cash stock compensation expense of $30 million and $19 million in fiscal 2022 and fiscal 2021, respectively. | ||||
NM represents that the percentage change is not meaningful. |
13-Week Period Ended Apr. 2, 2022 | 13-Week Period Ended Mar. 30, 2019 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 303,325 | $ | 440,083 | $ | (136,758) | (31.1) | % | |||||||||||||||
Interest (GAAP) | 124,018 | 94,514 | 29,504 | 31.2 | |||||||||||||||||||
Income taxes (GAAP) | 82,163 | (9,132) | 91,295 | NM | |||||||||||||||||||
Depreciation and amortization (GAAP) | 193,843 | 184,183 | 9,660 | 5.2 | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 703,349 | $ | 709,648 | $ | (6,299) | (0.9) | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
$ | 29,550 | $ | — | $ | 29,550 | NM | ||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
18,746 | 67,266 | (48,520) | (72.1) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
9,861 | 19 | 9,842 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(5,717) | — | (5,717) | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP)
(5)
|
$ | 755,789 | $ | 776,933 | $ | (21,144) | (2.7) | % |
(1)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(2)
|
Fiscal 2022 and fiscal 2019 include charges related to restructuring, severance, and facility closures, as well as various transformation initiative costs, primarily consisting of changes to our business technology strategy, excluding charges related to accelerated depreciation.
|
||||
(3)
|
Fiscal 2022 includes acquisition and due diligence costs. Fiscal 2019 represents acquisition costs. | ||||
(4)
|
Fiscal 2022 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $2 million and $5 million for fiscal 2022 and fiscal 2019, respectively, or non-cash stock compensation expense of $30 million and $24 million in fiscal 2022 and fiscal 2019, respectively. | ||||
NM represents that the percentage change is not meaningful. |
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 27, 2021 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 848,779 | $ | 373,116 | $ | 475,663 | 127.5 | % | |||||||||||||||
Interest (GAAP) | 495,131 | 438,988 | 56,143 | 12.8 | |||||||||||||||||||
Income taxes (GAAP) | 256,115 | 69,594 | 186,521 | 268.0 | |||||||||||||||||||
Depreciation and amortization (GAAP) | 571,606 | 542,471 | 29,135 | 5.4 | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 2,171,631 | $ | 1,424,169 | $ | 747,462 | 52.5 | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
$ | 29,550 | $ | — | $ | 29,550 | NM | ||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
69,093 | 89,253 | (20,160) | (22.6) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
28,260 | — | 28,260 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(19,216) | (162,372) | 143,156 | 88.2 | |||||||||||||||||||
Impact of loss on sale of business | — | 22,834 | (22,834) | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP) (5) | $ | 2,279,318 | $ | 1,373,884 | $ | 905,434 | 65.9 | % |
(1)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(2)
|
Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy, excluding charges related to accelerated depreciation. | ||||
(3)
|
Fiscal 2022 includes acquisition and due diligence costs. | ||||
(4)
|
Fiscal 2022 and fiscal 2021 represent the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $5 million and $12 million or non-cash stock compensation expense of $91 million and $65 million for fiscal 2022 and fiscal 2021, respectively. | ||||
NM represents that the percentage change is not meaningful. |
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 30, 2019 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 848,779 | $ | 1,138,505 | $ | (289,726) | (25.4) | % | |||||||||||||||
Interest (GAAP) | 495,131 | 270,643 | 224,488 | 82.9 | |||||||||||||||||||
Income taxes (GAAP) | 256,115 | 185,023 | 71,092 | 38.4 | |||||||||||||||||||
Depreciation and amortization (GAAP) | 571,606 | 576,596 | (4,990) | (0.9) | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 2,171,631 | $ | 2,170,767 | $ | 864 | 0.04 | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
$ | 29,550 | $ | — | $ | 29,550 | NM | ||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
69,093 | 215,051 | (145,958) | (67.9) | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
28,260 | 824 | 27,436 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
(19,216) | — | (19,216) | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP)
(5)
|
$ | 2,279,318 | $ | 2,386,642 | $ | (107,324) | (4.5) | % |
(1)
|
Represents a write-down of COVID-related personal protection equipment inventory due to the reduction in the net realizable value of inventory. | ||||
(2)
|
Fiscal 2022 and fiscal 2019 include charges related to restructuring, severance, and facility closures, as well as various transformation initiative costs, primarily consisting of changes to our business technology strategy, excluding charges related to accelerated depreciation. | ||||
(3)
|
Fiscal 2022 includes acquisition and due diligence costs. Fiscal 2019 represents acquisition costs. | ||||
(4)
|
Fiscal 2022 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $5 million and $4 million or non-cash stock compensation expense of $91 million and $78 million for fiscal 2022 and fiscal 2019, respectively. | ||||
NM represents that the percentage change is not meaningful. |
39-Week Period Ended Apr. 2, 2022 | 39-Week Period Ended Mar. 27, 2021 | ||||||||||
(In thousands) | |||||||||||
Net cash provided by operating activities (GAAP) | $ | 745,871 | $ | 1,479,784 | |||||||
Additions to plant and equipment | (327,535) | (251,167) | |||||||||
Proceeds from sales of plant and equipment | 15,946 | 19,308 | |||||||||
Free Cash Flow (Non-GAAP)
(1)
|
$ | 434,282 | $ | 1,247,925 | |||||||
Acquisition of businesses, net of cash acquired | $ | (1,281,835) | $ | — | |||||||
Debt borrowings (repayments), net | 1,213,114 | (1,897,688) | |||||||||
Redemption premiums and repayments of senior notes | (1,395,668) | — | |||||||||
Stock repurchases | (415,824) | — | |||||||||
Dividends paid | (719,865) | (689,251) | |||||||||
(1)
|
Free cash flow should not be used as a substitute for the most comparable GAAP measure in assessing the company’s liquidity for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Key Performance Indicators” contained in our fiscal 2021 Form 10-K for discussions around this non-GAAP performance metric.
|
Combined Parent and Guarantor Subsidiaries Summarized Balance Sheet | Apr. 2, 2022 | Jul. 3, 2021 | ||||||||||||
(In thousands) | ||||||||||||||
ASSETS | ||||||||||||||
Receivables due from non-obligor subsidiaries | $ | 503,761 | $ | 171,718 | ||||||||||
Current assets | 5,617,406 | 6,661,284 | ||||||||||||
Total current assets | $ | 6,121,167 | $ | 6,833,002 | ||||||||||
Notes receivable from non-obligor subsidiaries | $ | 85,520 | $ | 83,457 | ||||||||||
Other noncurrent assets | 3,936,594 | 3,933,833 | ||||||||||||
Total noncurrent assets | $ | 4,022,114 | $ | 4,017,290 | ||||||||||
LIABILITIES | ||||||||||||||
Payables due to non-obligor subsidiaries | $ | 54,625 | $ | 203,365 | ||||||||||
Other current liabilities | 2,471,341 | 2,299,674 | ||||||||||||
Total current liabilities | $ | 2,525,966 | $ | 2,503,039 | ||||||||||
Notes payable to non-obligor subsidiaries | $ | 166,211 | $ | 269,709 | ||||||||||
Long-term debt | 10,053,274 | 10,139,596 | ||||||||||||
Other noncurrent liabilities | 1,253,153 | 1,209,598 | ||||||||||||
Total noncurrent liabilities | $ | 11,472,638 | $ | 11,618,903 |
Combined Parent and Guarantor Subsidiaries Summarized Results of Operations | 39-Week Period Ended Apr. 2, 2022 | |||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Sales | $ | 31,739,026 | ||||||||||||||||||||||||
Gross profit | 5,677,552 | |||||||||||||||||||||||||
Operating income | 1,588,760 | |||||||||||||||||||||||||
Interest expense from non-obligor subsidiaries | 45,904 | |||||||||||||||||||||||||
Net earnings | 824,163 |
ISSUER PURCHASES OF EQUITY SECURITIES | |||||||||||||||||||||||
Period |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(2)
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||
Month #1 | |||||||||||||||||||||||
January 2 - January 29 | 1,297 | $ | 77.07 | 99,960 | — | ||||||||||||||||||
Month #2 | |||||||||||||||||||||||
January 30 - February 26 | 4,932 | 83.80 | 413,303 | — | |||||||||||||||||||
Month #3 | |||||||||||||||||||||||
February 27 - April 2 | — | — | — | — | |||||||||||||||||||
Totals | 6,229 | $ | 82.40 | 513,263 | — |
3.1 | — | |||||||
3.2 | — | |||||||
3.3 | — | |||||||
3.4 | — | |||||||
22.1# | — | |||||||
31.1# | — | |||||||
31.2# | — | |||||||
32.1# | — | |||||||
32.2# | — | |||||||
101.SCH# | — | Inline XBRL Taxonomy Extension Schema Document | ||||||
101.CAL# | — | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||||
101.DEF# | — | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||||
101.LAB# | — | Inline XBRL Taxonomy Extension Labels Linkbase Document | ||||||
101.PRE# | — | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||||
104 | — | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Sysco Corporation | ||||||||
(Registrant) | ||||||||
Date: May 10, 2022 | By: | /s/ KEVIN P. HOURICAN | ||||||
Kevin P. Hourican | ||||||||
President and Chief Executive Officer | ||||||||
Date: May 10, 2022 | By: | /s/ AARON E. ALT | ||||||
Aaron E. Alt | ||||||||
Executive Vice President and | ||||||||
Chief Financial Officer | ||||||||
Date: May 10, 2022 | By: | /s/ ANITA A. ZIELINSKI | ||||||
Anita A. Zielinski | ||||||||
Senior Vice President and | ||||||||
Chief Accounting Officer |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Suppliers
Supplier name | Ticker |
---|---|
Berry Global Group, Inc. | BERY |
Silgan Holdings Inc. | SLGN |
Ball Corporation | BLL |
AptarGroup, Inc. | ATR |
Heartland Express, Inc. | HTLD |
Ingredion Incorporated | INGR |
Bemis Company, Inc. | BMS |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|